Delivery Order SPE2DB22D2006-SPE2DB24FW3AM

Award Date 8/20/24
Potential Completion Date 9/11/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $13,971.12 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 200-unit vials of the pharmaceutical product Botox, with a completion date of June 4, 2024. This order is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the...
This is a $29,106.50 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the delivery of 200-unit vials of BOTOX with an ultimate completion date of August 8, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of essential medical commodities to various federal agencies and healthcare programs, including the military. This award is likely part...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of Botox. The contract is a firm-fixed-price delivery order with a ceiling value of $13,971.12 and an ultimate completion date of October 17, 2024. The contract does not have a set-aside designation. Amerisourcebergen has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by various defense and...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract valued at $13,971.12 to Amerisourcebergen Drug Corp for the supply of 200 unit vials of BOTOX. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999, for the provision of a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The...
The U.S. Defense Logistics Agency (DLA) awarded a $13,971.12 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 200-unit Botox vials. This contract is a part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company, to provide Botox 200 unit vials. The order has a ceiling value of $17,463.90 and a period of performance through April 12, 2024. AmerisourceBergen Drug Corp is the prime contractor, and this award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that runs through...
This $58,213 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of the medication Botox. The contract has an ultimate completion date of September 20, 2024 and is not a set-aside award. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for delivering a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of 200 unit BOTOX vials. The $8,731.95 firm-fixed-price contract has an ultimate completion date of September 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this contract without any set-aside designation. This contract is likely part of a larger Indefinite Delivery Contract (IDC) vehicle that AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,971.12 firm fixed-price delivery order is for the supply of 200-unit vials of BOTOX medication. The contract has a completion date of November 8, 2024 and was awarded on October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical which serves...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $13,971.12 contract is for the supply of 200 unit vials of the medical drug Botox, with a performance period through April 9, 2024. This delivery order is placed under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW3AM
    Delivery Order

This is a $13,971.12 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 200-unit vials of Botox. The contract has an ultimate completion date of September 11, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a wide range of medical commodities to support military treatment programs and facilities worldwide. This contract does not have a set-aside designation.

Generated 11/19/24, 9:19 AM